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Abstract
Introduction: It is generally accepted that mitochondria are a primary source of intracellular reactive oxygen species (ROS). 
Under physiological circumstances they are permanently formed as by-products of aerobic metabolism in the mitochondria. To 
counter the harmful effect of ROS, cells possess an antioxidant defence system to detoxify ROS and avert them from accumu-
lation at high concentrations. Mitochondria-located manganese superoxide dismutase (MnSOD, SOD2) successfully converts 
superoxide to the less reactive hydrogen peroxide (H
2O2). To the best of our knowledge, there are no available data regarding 
immunohistochemical expression of MnSOD in colorectal neoplastic tissues. 
Aim: To investigate the immunohistochemical expression status of MnSOD in colorectal premalignant and malignant lesions. 
Material and methods: This study was performed on resected specimens obtained from 126 patients who had undergone 
surgical resection for primary sporadic colorectal cancer, and from 114 patients who had undergone colonoscopy at the Munic-
ipal Hospital in Jaworzno (Poland). Paraffin-embedded, 4-μm-thick tissue sections were stained for rabbit polyclonal anti SOD2 
antibody obtained from GeneTex (clone TF9-10-H10 from America Diagnostica).
Results: Results of our study demonstrated that the development of colorectal cancer is connected with increased expres-
sion of MnSOD both in adenoma and adenocarcinoma stages. Samples of adenocarcinoma with G2 and G3 grade showed 
significantly higher levels of immunohistochemical expression of this antioxidant enzyme. Moreover, patients with the presence 
of lymphovascular invasion and higher degree of regional lymph node status have been also characterised by higher levels of 
MnSOD expression. The samples of adenoma have been characterised by higher levels of MnSOD expression in comparison to 
normal mucosa as well. Interestingly, there was no significant correlation between expression and histological type of adenoma. 
Conclusions: Development of colorectal cancer is connected with increased expression of MnSOD both in adenoma and 
adenocarcinoma stages.
Introduction
It is generally accepted that mitochondria are a pri-
mary source of intracellular reactive oxygen species 
(ROS). Under physiological circumstances they are 
permanently formed as by-products of aerobic metab-
olism in the mitochondria [1]. During mitochondrial 
respiration, the tricarboxylic acid (TCA) cycle generates 
reducing components acting as a source for electrons. 
Electron transfer between mitochondrial electron trans-
port complexes sets up a proton gradient for ATP syn-
thesis [2]. Nevertheless, it has been documented that 
electrons can flee from the electron transport chain and 
react with oxygen molecules to form superoxide anions, 
which is the primary member in a wide array of the ROS 
family. It is worth mentioning that roughly 1–5% of the 
total oxygen consumed during respiration process is 
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transformed to superoxide radicals. Superoxide is highly 
reactive and toxic. It may react with nitric oxide, anoth-
er free radical generated by mitochondrial nitric oxide 
synthase, to the highly reactive peroxynitrite. These ROS 
are major factors responsible for heavy damage to mito-
chondrial lipids, proteins, and nucleic acids [3–5].
To counter the harmful effect of ROS, cells possess 
an antioxidant defence system to detoxify ROS and 
avert them from accumulation at high concentrations 
[6]. The mitochondria-located manganese superoxide 
dismutase (MnSOD, SOD2) successfully converts su-
peroxide to the less reactive hydrogen peroxide (H2O2), 
which may break down further into water and dioxygen 
by other enzymatic and non-enzymatic antioxidants [7]. 
Because superoxide primarily emerges from mitochon-
dria, mitochondrial MnSOD is thought to have a funda-
mental role in ROS detoxification [8].
As revealed by studies, MnSOD plays a very signifi-
cant role in maintenance of homeostasis in the gastro-
intestinal tract [9]. To the best of our knowledge, there 
are no available data regarding immunohistochemical 
expression of MnSOD in colorectal neoplastic tissues. 
Colorectal cancer arises from the lesions known as 
adenomatous polyps, commonly called adenomas. Al-
though every adenoma has the capacity of malignant 
transformation very few adenomas develop into cancer 
[10]. A survey comparing adenoma prevalence and car-
cinoma incidence demonstrated that the percentage of 
transformation is about 0.25% per year [11].
Aim
Therefore, in the present study we investigated the 
immunohistochemical expression status of MnSOD in 
colorectal premalignant and malignant lesions. The 
correlations with significant clinicopathological varia-
bles and MnSOD expression in colorectal cancer and 
adenoma patients were also determined.  
Material and methods
The group of patients
This study was performed on resected specimens 
obtained from 126 patients who had undergone sur-
gical resection for primary sporadic colorectal cancer, 
and from 114 patients who had undergone colonoscopy 
at the Municipal Hospital in Jaworzno (Poland). All the 
specimens were obtained with the consent of the pa-
tients. In all cases, a experienced pathologist reviewed 
the haematoxylin and eosin (H + E) slides of the ade-
nomas or primary tumours to confirm the pathological 
features.
The subject population of colorectal cancer patients 
comprised 83 men and 43 women. The tumours of the 
patients were classified histopathologically as adeno-
carcinoma according to the WHO grading system: grade 
1 – 8 (6.349%) patients; grade 2 – 71 (56.349%) pa-
tients; grade 3 – 47 (37.301%) patients. 
The population of patients with adenoma comprised 
53 men and 61 women. The adenomatous polyps were 
classified as tubular adenomas – 64 (56.140%) patients; 
villous adenomas – 28 (24.561%) patients; and tubulo- 
villous adenomas – 22 (19.298%) patients.
The design of the study was approved by the ethical 
committee of the Jerzy Kukuczka Academy of Physical 
Education in Katowice. The study was supported by 
grant KNW-1-017/N/3/0 of the Medical University of 
Silesia.
Immunohistochemistry of MnSOD 
protein
Paraffin-embedded, 4-μm-thick tissue sections 
were stained for rabbit polyclonal anti SOD2 antibody 
obtained from GeneTex (clone TF9-10-H10 from Amer-
ica Diagnostica). Deparaffinisation of all sections was 
performed through a series of xylene baths, and re-
hydration was performed through graded alcohols. To 
retrieve the antigenicity, tissue sections were treated 
three times with microwaves in a 10 mM citrate buffer 
(pH 6.0) for 5 min each. Subsequently, antigen retriev-
al sections were incubated with rabbit polyclonal an-
ti-SOD2 antibody (final dilution 1 : 400). The En-Vision 
method (DAKO En-Vision Kit/Alakline Phosphatase 
detection system) was used according to the manu-
facturer’s instructions. The bound primary antibody 
was detected using the New Fuchsin Substrate System 
(DAKO A/S).
Immunohistochemical analysis
We graded the immunoreactivity by using a semi-
quantitative approach. Immunohistochemical reaction 
for MnSOD was classified into four groups according to 
the intensity of immunohistochemical reaction: 0, neg-
ative; 1, weak; 2, moderate; and 3, strong. The intensity 
of immunohistochemical reaction on the surface epithe-
lial cells has been described as strongly positive. Diffuse 
staining with the staining intensity weaker than that of 
surface epithelial cells was characterised as moderately 
positive. Faint or focal staining was described as weakly 
positive. Heterogeneity was defined as the proportion 
of cancer cells showing a positive reaction to the to-
tal number of cancer cells and was graded from 0 to 
3 by assessment: 0 demonstrated negative staining, 
1 represented less than 10%, 2 represented 10–50%, and 
3 represented more than 50% of cancer cells with pos-
itive reaction. The results of intensity of staining and 
heterogeneity were combined and scored as follows: 
0 represented negative, 1 and 2 represented low, 3 and 
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4 represented moderate, and 5 and 6 represented high 
expression. 
Statistical analysis
The relationship between MnSOD expression and 
clinicopathological variables were examined by the R: 
A Language and Environment for Statistical Comput-
ing (R Core Team., Vienna, Austria) using Pearson’s c2 
test. The accepted level of statistical significance was 
p < 0.05.
Results
In normal colorectal mucosa MnSOD was predom-
inantly localised in the basal cytoplasm of surface ep-
ithelial cells, in which MnSOD immunoexpression was 
characterised as strong and granular (Figure 1 A). In 
some glandular epithelial cells of the crypts MnSOD ex-
pression was also observed. Its intensity was described 
as weak. Weak expression was also detected in mus-
cularis mucosa and blood vessels in submucosa (Fig- 
ure 1 B). The scattered inflammatory cells localised 
within lamina propria showed moderate and strong cy-
toplasmic expression of MnSOD.
In adenoma samples strong granular immunoex-
pression was detected in neoplastic cells (Figures 1 
C, D). In inflammatory cells within lamina propria ex-
pression was characterised as moderate or strong. The 
scattered fibroblast-like cells that were found in close 
proximity to neoplastic glands were also immunoposi-
tive. In those stromal cells, MnSOD immunoexpression 
was characterised as strong and granular. Adenomas 
with high grade of dysplasia revealed a significantly 
higher expression of MnSOD in comparison to those 
with low grade of dysplasia (c2 = 13.5429; df = NA; 
p = 0.0004998). Moreover, adenomas with high grade 
of inflammatory infiltration revealed significantly high-
er expression of this enzyme (c2 = 93.4386; df = 7; 
p = 2.2e-16). There was no correlation between inten-
sity of MnSOD immunoreactions and age, gender, lo-
calisation, and histological type of adenoma (Table I). 
In adenocarcinoma samples, MnSOD expression was 
found in the cytoplasm of both stromal and cancer cells 
(Figures 1 E, F). Also, the walls of blood vessels showed 
positive immunoreactions, but the intensity was weak. 
The scattered cells with positive reaction were found in 
submucosa and fatty tissue as well. Immunohistochem-
ical expression of MnSOD in adenocarcinoma samples 
was significantly correlated with histological grade of 
tumour (c2 = 19.1451; df = NA; p = 0.008496), lympho-
vascular invasion (c2 = 16.6624; df = 3; p = 0.0008292), 
and regional lymph node involvement (c2 = 12.9936; 
df = NA; p = 0.04248) (Table II). There was no correla-
tion between MnSOD immunoexpression and age, 
gender, size of primary tumour, location, and depth of 
invasion.
Discussion
Numerous reports have implicated ROS and the acti-
vation of redox-sensitive signalling pathways as pivotal 
players in neoplasm development [12, 13]. Moreover, it 
has been reported that intrinsic antioxidant enzymes 
are vital to the regulation of oxidative stress within 
cells, and alterations of these enzymes are connected 
with cancer pathogenesis as well [14]. Of these, one 
of the primary cellular antioxidants SOD catalyses the 
conversion of superoxide to H
2O2, which can then be 
removed by catalase, glutathione peroxidases, or per-
oxiredoxins. In vitro studies have shown that a number 
of cancer cell lines contain elevated levels of MnSOD 
and decreased levels of catalase, and that this disrup-
tion in steady-state level of H
2O2 showed a correlation 
with increased metastasis, proliferation, and resistance 
to apoptosis. MnSOD-dependent production of H
2O2 
increased the expression of matrix-degrading metal-
loproteinases (MMP), which can alter the cancer mi-
croenvironment, forming a permissive conditions for 
metastatic disease [15, 16]. For example, Hempel et al. 
demonstrated that acquisition of metastatic phenotype 
was associated with a significant increase in the expres-
sion and activity of MnSOD and decreased activity of 
catalase. This, in turn, was associated with enhanced 
steady-state production of H
2O2 in the 253J B-V cells, 
and with increased activity of MMP-9 and VEGF [17]. Liu 
et al. determined that MnSOD expression was consis-
tently elevated in patients with tongue cancer. In such 
patients, expression of MnSOD was significantly high-
er in cases with lymph node metastases [18]. Several 
studies demonstrated increased expression of MnSOD 
in oesophageal [19–24], oral squamous cell carcinoma 
[25], and pancreatic cancer [26]. In some cases en-
hanced MnSOD expression was related to poor survival 
rate or recurrence. Nozoe et al. revealed that the pro-
portion of lymph node metastasis in MnSOD-positive 
colorectal carcinomas was significantly higher than in 
MnSOD-negative carcinomas. Moreover, the survival 
rate in patients with MnSOD-positive carcinomas was 
worse than that in patients with MnSOD-negative car-
cinomas [27]. Similar findings have been detected in 
gastric [19, 28–32] and pancreatic cancer [25], and oral 
squamous cell carcinoma. The question arises regard-
ing the reasons for enhanced activity of MnSOD in the 
metastatic stage of the disease. Dhar et al. suggested 
that reduced Sp1 binding to the MnSOD promoter is 
responsible for decreased MnSOD expression in the ear-
ly stages of cancer development, whereas reduced p53 
binding activity is responsible for restoration of MnSOD 
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at later stages of cancer development. In this case, the 
balance between Sp1 and p53 plays an important role 
in regulating the MnSOD level during the phenotyp-
ic changes leading to aggressive growth. It has been 
suggested that increased MnSOD activity may protect 
cells against mitochondrial injury, thereby conferring 
Figure 1. Expression of MnSOD in normal colorectal tissue, colorectal adenomas, and cancer. A – Immuno-
histochemical reaction in colorectal surface epithelium (arrows). B – Positive immunohistochemical reaction 
in the colorectal crypts (arrows), muscularis mucosa (arrowhead), and walls of the blood vessels (red arrow-
head). C, D – Weak (C) and strong (D) immunoreactions in neoplastic colorectal crypts in adenoma patients. 
E, F – Positive immunoreaction for MnSOD in colorectal cancer tissues; strong reaction detected in cancerous 
cells (arrowheads) and stromal cells (E1 – arrows)
E
C
A
F
D
B
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a growth advantage to the cancer cells acquiring a more 
aggressive behaviour [9, 33].
In vitro studies also showed that elevated levels of 
MnSOD were correlated with acquisition of invasive 
abilities. It is generally accepted that the major process 
responsible for cell metastatic behaviour is epitheli-
al mesenchymal transition (EMT) [34]. Interestingly, 
transcription factors involved in EMT activation seem 
to be under the influence of MnSOD. Both Snail1 and 
Snail2 were highly expressed in metastatic UM1 cells 
in comparison to UM2 cells. Upon MnSOD knockdown 
in UM1 cells, the intracellular levels of H
2O2 levels were 
decreased and the expression of Snail factors was in-
hibited. Moreover, the level of Snail factors was correlat-
ed with MMP-1 and ERK1/2. These results may indicate 
that MnSOD activates Snail signalling, increasing the 
same metastatic properties of cancer cells [18].
The results of our study remain in agreement 
with the findings mentioned above. We also revealed 
that samples of colorectal adenocarcinoma showed 
significantly higher immunoexpression of MnSOD in 
comparison to adenomas and adjacent mucosa with-
out any pathological lesions. High intensity of immu-
noreactions was detected in G3 tumours, which are 
known to be highly metastatic. Moreover, expression 
of MnSOD was correlated with lymphovascular inva-
sion and regional lymph node involvement. Approxi-
mately 50% of patients with lymphovascular invasion 
showed strong expression of MnSOD, whereas only 
15% from the negative group showed a strong pat-
tern of MnSOD expression. As we discovered, region-
al lymph node involvement was also correlated with 
MnSOD positivity. The majority of patients with N2 
status showed strong expression, whereas only 1 pa-
tient from the N0 group showed such strong reaction 
intensity. 
MnSOD expression was also upregulated in the case 
of colorectal adenomas, which are known as precursor 
lesions of carcinoma. Adenomas with high grade of 
dysplasia have significantly higher level of MnSOD im-
munoexpression. Only 2 patients from the group char-
acterised with a high degree of dysplasia were negative, 
whereas 45% demonstrated strong expression. Similar 
results have been obtained in patients with strong in-
filtration of immune cells in lamina propria. Half of the 
cases revealed strong expression, whereas only 3 were 
described as negative. On the other hand, patients from 
the group characterised by weak infiltration did not 
show negative immunoreaction. Most of them showed 
moderate reaction and only 15 % revealed strong in-
tensity. It is not surprising that inflammatory infiltra-
tion is an important factor that can influence MnSOD 
expression pattern. As revealed by studies, MnSOD is 
detected not only within cytoplasm of neoplastic cells 
but also in stromal cells, including macrophages and 
neutrophils. Accumulating phagocytic leukocytes gener-
Table I. Relation between MnSOD expression and clinicopathological variables in colorectal adenoma patients
Variables Total Expression status, n (%) P-value
Negative Low Moderate High 
Age < 50 56 9 (16.07) 25 (44.64) 16 (28.57) 6 (10.71) 0.1009
≥ 50 58 12 (20.69) 16 (27.59) 27 (46.55) 3 (5.17)
Gender Male 53 11 (20.75) 16 (30.19) 22 (41.51) 4 (7.55) 0.6647
Female 61 10 (16.39) 25 (40.98) 23 (37.70) 3 (4.92)
Location Proximal colon 60 10 (16.67) 18 (30.00) 29 (48.33) 3 (5.00) 0.07096
Distal colon 30 5 (16.67) 12 (40.00) 11 (36.67) 2 (6.67)
Rectum 24 9 (37.50) 11 (45.83) 3 (12.50) 1 (4.17)
Inflammatory 
infiltrate
Weak 39 0 (0.00) 8 (20.51) 25 (64.10) 6 (15.38) < 0.001
Strong 75 3 (4.00) 10 (13.33) 21 (28.00) 41 (54.67)
Degree of 
dysplasia
Low grade 43 1 (2.33) 9 (20.93) 26 (60.47) 7 (16.28) 0.0004998
High grade 71 2 (2.82) 17 (23.94) 20 (28.17) 32 (45.07)
Histological 
type of 
adenoma
Tubular 64 11 (17.19) 19 (29.69) 31 (48.44) 3 (4.69) 0.1719
Villous 28 5 (17.86) 10 (35.71) 11 (39.29) 2 (7.14)
Tubulo-villous 22 7 (31.82) 11 (50.00) 3 (13.64) 1 (4.55)
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Table II. Relation between MnSOD expression and clinicopathological variables in colorectal cancer patients
Variables Total number 
of cases
Expression status, n (%) P-value
Negative Low Moderate High 
Age:
< 50 33 10 (30.30) 4 (12.12) 10 (30.30) 9 (27.27) 0.1654
≥ 50 93 20 (21.51) 5 (5.38) 23 (24.73) 45 (48.39)
Gender:
Male 83 17 (20.48) 6 (7.23) 24 (28.92) 36 (43.37) 0.2529
Female 43 16 (37.21) 3 (6.98) 9 (20.93) 15 (34.88)
Size of primary tumour:
< 5 cm 44 11 (25.00) 0 (0.00) 13 (29.55) 20 (45.45) 0.1844
≥ 5 cm 82 22 (26.83) 8 (9.76) 19 (23.17) 33 (40.24)
Location of tumour:
Proximal colon 31 3 (9.68) 3 (9.68) 10 (32.26) 15 (48.39) 0.2784
Distal colon 83 25 (30.12) 7 (8.43) 17 (20.48) 34 (40.96)
Rectum 12 3 (25.00) 2 (16.67) 4 (33.33) 3 (25.00)
Histological grade:
G3 47 2 (4.26) 3 (6.38) 10 (21.28) 32 (68.09) 0.008496
G2 71 7 (9.86) 4 (5.63) 17 (23.94) 43 (60.56)
G1 8 2 (25.00) 3 (37.50) 3 (37.50) 0 (0.00)
Depth of invasion:
T1 6 2 (33.33) 1 (16.67) 2 (33.33) 1 (16.67) 0.1159
T2 30 6 (20.00) 7 (23.33) 9 (30.00) 8 (26.67)
T3 68 9 (13.24) 15 (22.06) 21 (30.88) 23 (33.82)
T4 22 1 (4.55) 9 (40.91) 11 (50.00) 1 (4.55)
Lymphovascular invasion:
Positive 85 10 (11.76) 15 (17.65) 19 (22.35) 41 (48.24) 0.0008292
Negative 41 11 (26.83) 6 (14.63) 18 (43.90) 6 (14.63)
Regional LN involvement:
N2 83 21 (25.30) 7 (8.43) 21 (25.30) 34 (40.96) 0.04248
N1 31 1 (3.23) 3 (9.68) 11 (35.48) 16 (51.61)
N0 12 3 (25.00) 2 (16.67) 6 (50.00) 1 (8.33)
ates high local concentration of H2O2 for prolonged time 
periods [35]. Kruidenier et al. demonstrated that they 
also contain high MnSOD levels. Interestingly, we did 
not observe any correlation between MnSOD expression 
and histological type of adenoma [36]. It is generally 
accepted that villous polyps in particular are considered 
high risk. With respect to malignancy, it was found that 
only 4% of tubular adenomas but 40% of villous adeno-
mas developed into carcinoma [37]. It may take about 
10 years for an adenomatous polyp to transform into 
cancer [38].
At this point it is worth noting that increased 
MnSOD content in aggressive cancer cells may contrib-
ute to the repair of mitochondrial function allowing the 
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cells to utilise oxidative phosphorylation for maximum 
energy production to increase cell survival and growth. 
In the early stages of tumorigenesis, lower MnSOD con-
tent may be a threat to mitochondrial function, leading 
to a shift to glycolysis in cancer cells. Alternatively, it 
has been proposed that glycolytic metabolism arises as 
an adaptive response to hypoxic conditions during the 
early stages of tumour development because it permits 
ATP generation even in the absence of oxygen. Thus, 
excess lactate production may further drive the evolve-
ment of glycolytic metabolism for energy production 
[39]. It has been also proposed that aerobic glycolysis 
in tumour cells may require rapid influx of substrates 
through glycolysis, allowing the effective shutting of 
glucose or fructose as a source of carbon energy pro-
duction [40–42]. However, because of the consistently 
increasing demand for energy during the aggressive 
growth of cancer cells, particularly in the later stages of 
carcinogenesis, the energy supply from glycolytic pro-
cesses may not be sufficient. In this situation, it is pos-
sible that aggressive cancer cells switch back from gly-
colysis to oxidative phosphorylation for their increased 
energy requirements. For this purpose, cancer cells need 
to increase the efficiency of mitochondrial function [9].
Conclusions
The results of our study have demonstrated that 
development of colorectal cancer is connected with 
increased expression of MnSOD both in adenoma and 
adenocarcinoma stages. Samples of adenocarcinoma 
with G2 and G3 grade showed significantly higher lev-
els of immunohistochemical expression of this antiox-
idant enzyme. Moreover, patients with the presence of 
lymphovascular invasion and higher degree of regional 
lymph node status were also characterised by higher 
level of MnSOD expression. The samples of adenoma 
were characterised by higher level of MnSOD expres-
sion in comparison to normal mucosa as well. Inter-
estingly, there was no significant correlation between 
expression and histological type of adenoma. 
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